Terms: = Lymphoma AND TRD AND Treatment
12 results:
1. Outcomes of adolescents with acute lymphoblastic leukaemia.
Feng J; Cheng FWT; Chiang AKS; Lam GKS; Chow TTW; Ha SY; Luk CW; Li CH; Ling SC; Yau PW; Ho KKH; Leung AWK; Chan NPH; Ng MHL; Li CK
Hong Kong Med J; 2022 Jun; 28(3):204-214. PubMed ID: 35697524
[TBL] [Abstract] [Full Text] [Related]
2. First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas-a single-centre experience in 61 patients.
Brezina T; von Dewitz H; Schroeder T; Ullrich S; Nachtkamp K; Reifenberger G; Malzkorn B; Sabel M; Haas R; Kobbe G
Ann Hematol; 2022 Mar; 101(3):607-616. PubMed ID: 34982196
[TBL] [Abstract] [Full Text] [Related]
3. Chromosome Translocation t(14;21)(q11;q22) Activates Both
Panagopoulos I; Gorunova L; Johannsdottir IMR; Andersen K; Holth A; Beiske K; Heim S
Cancer Genomics Proteomics; 2020; 17(1):41-48. PubMed ID: 31882550
[TBL] [Abstract] [Full Text] [Related]
4. The therapeutic efficacy of pediatric ALL patients with MLL gene rearrangement treated with CCLG-ALL2008 protocol.
Sun YN; Hu YX; Gao L; Xiao PF; Lu J; Wu SY; Wang M; Shao XJ; Zhou CY; Ling J; Li JQ; Pan J; Gao J; Hu SY
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):6020-6029. PubMed ID: 30280786
[TBL] [Abstract] [Full Text] [Related]
5. Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer.
Li F; Qi J; Qin C; Fu Z; Ren W
Oncol Rep; 2018 Dec; 40(6):3743-3751. PubMed ID: 30272302
[TBL] [Abstract] [Full Text] [Related]
6. Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.
Tomizawa D; Watanabe T; Hanada R; Horibe K; Horikoshi Y; Iwamoto S; Kinoshita A; Moritake H; Nakayama H; Shimada A; Taga T; Takahashi H; Tawa A; Terui K; Hori H; Kawano Y; Kikuta A; Manabe A; Adachi S
Int J Hematol; 2015 Sep; 102(3):318-26. PubMed ID: 26126642
[TBL] [Abstract] [Full Text] [Related]
7. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
[TBL] [Abstract] [Full Text] [Related]
8. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia.
Lund B; Åsberg A; Heyman M; Kanerva J; Harila-Saari A; Hasle H; Söderhäll S; Jónsson ÓG; Lydersen S; Schmiegelow K;
Pediatr Blood Cancer; 2011 Apr; 56(4):551-9. PubMed ID: 21298739
[TBL] [Abstract] [Full Text] [Related]
9. A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03.
Hitz F; Martinelli G; Zucca E; von Moos R; Mingrone W; Simcock M; Peterson J; Cogliatti SB; Bertoni F; Zimmermann DR; Ghielmini M;
Hematol Oncol; 2009 Sep; 27(3):154-9. PubMed ID: 19274614
[TBL] [Abstract] [Full Text] [Related]
10. treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001.
Christensen MS; Heyman M; Möttönen M; Zeller B; Jonmundsson G; Hasle H;
Br J Haematol; 2005 Oct; 131(1):50-8. PubMed ID: 16173962
[TBL] [Abstract] [Full Text] [Related]
11. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis.
Borgmann A; von Stackelberg A; Hartmann R; Ebell W; Klingebiel T; Peters C; Henze G;
Blood; 2003 May; 101(10):3835-9. PubMed ID: 12732501
[TBL] [Abstract] [Full Text] [Related]
12. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
Hargrave DR; Hann II; Richards SM; Hill FG; Lilleyman JS; Kinsey S; Bailey CC; Chessells JM; Mitchell C; Eden OB;
Br J Haematol; 2001 Feb; 112(2):293-9. PubMed ID: 11167821
[TBL] [Abstract] [Full Text] [Related]
